paloma-3: palbociclib and fulvestrant for hr-/her metastatic breast cancer
Published 5 years ago • 1.3K plays • Length 5:04Download video MP4
Download video MP3
Similar videos
-
2:45
paloma-3: phase 3 trial of fulvestrant with palbociclib for metastatic breast cancer
-
3:02
paloma-3: palbociclib plus fulvestrant in hormone receptor-positive advanced breast cancer
-
5:10
paloma-3: overall survival (os) with palbociclib plus fulvestrant in hr ,her2_ abc
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
6:56
analyses from paloma-3 study, including os data for hr breast cancer
-
1:53
palbociclib & fulvestrant for breast cancer
-
1:05
dr. verma on palbociclib plus fulvestrant for hr /her2- breast cancer
-
1:29
capitello-292: capivasertib, palbociclib, and fulvestrant for hr endocrine-resistant breast cancer
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
0:55
dr. turner discusses the paloma-3 trial
-
13:22
palbociclib and breast cancer
-
2:46
preliminary data on op-1250 palbociclib in advanced/metastatic er /her- breast cancer
-
1:05
dr. turner discusses the paloma-3 trial
-
4:16
fulvestrant with or without palbociclib in receptor-positive, her2-negative metastatic breast cancer
-
0:55
fulvestrant plus palbociclib in breast cancer
-
39:21
bcfnz webinar: palbociclib (ibrance) for advanced or metastatic hr breast cancer - nz update
-
5:04
abemaciclib fulvestrant at progression of hr mbc